SCHEMBL7868320

SCHEMBL7868320

COC(Cc1ccccc1)CC1CCNCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.51
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
SLC6A2 P23975 4/20 0.40
SLC6A4 P31645 4/20 0.40
HRH1 P35367 3/20 0.40
SIGMAR1 Q99720 1/20 0.39
HTR1A P08908 2/20 0.38
SLC6A3 Q01959 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
ITGB3 P05106 3/20 0.37
ITGA2B P08514 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868325 1.00 GBA1 (0.51) GBA1GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL27377143 0.81 GBA1 (0.47) GBA1SLC6A2SLC6A4HRH1HTR1A
SCHEMBL7492670 0.80 GBA1 (0.56) GBA1GRIN2DGRIN3BADRA1DADRA1A
SCHEMBL7492665 0.80 GBA1 (0.56) GBA1GRIN2DGRIN3BADRA1DADRA1A
Hydrochloric Acid SCHEMBL7404805 0.77 SLC6A2 (0.46) GBA1SLC6A2SLC6A4HRH1SLC6A3
SCHEMBL7870849 0.77 GBA1 (0.40) GBA1ITGB3ITGA2B
SCHEMBL7870841 0.77 GBA1 (0.40) GBA1ITGB3ITGA2B
SCHEMBL7871223 0.76 GBA1 (0.56) GBA1GRIN2BSLC6A2SLC6A4HRH1
SCHEMBL9264658 0.76 GBA1 (0.56) GBA1SLC6A2SLC6A4HRH1SIGMAR1
SCHEMBL7871873 0.76 GBA1 (0.56) GBA1GRIN2DGRIN3BADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed
WO-2000051608-A1 3-THIENYL AND 3-FURANYL PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-09-08 WO disclosed